Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard E Gendelman

Showing results (71-80 of 354) with videos related to

Pageof 36
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR TherapyJonathan Herskovitz, Mahmudul Hasan, Milankumar Patel, et al.
Antioxidants & Redox Signaling|February 27, 2009
Innate and adaptive immunity for the pathobiology of Parkinson's diseaseDavid K Stone, Ashley D Reynolds, R Lee Mosley, et al.
Neurobiology of Disease|January 2, 2010
HIV-1 neuroimmunity in the era of antiretroviral therapyStephanie D Kraft-Terry, Andrew R Stothert, Shilpa Buch, et al.
Blood|November 16, 2007
STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrierAnathbandhu Chaudhuri, Bo Yang, Howard E Gendelman, et al.
Trends in Microbiology|April 15, 2019
The Promise of Long-Acting Antiretroviral Therapies: From Need to ManufactureHoward E Gendelman, JoEllyn McMillan, Aditya N Bade, et al.
Neuron|October 21, 2009
A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infectionStephanie D Kraft-Terry, Shilpa J Buch, Howard S Fox, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDSStephen Dewhurst, Sanjay B Maggirwar, Giovanni Schifitto, et al.
Communications Biology|July 19, 2025
Unique molecular signatures in rebound viruses from antiretroviral drug and CRISPR-treated HIV-1-infected humanized miceChen Zhang, Haotian Li, Larisa Y Poluektova, et al.
Journal of Parkinson'S Disease|July 24, 2022
Therapeutic Strategies for Immune Transformation in Parkinson's DiseaseMaamoon Saleh, Milica Markovic, Katherine E Olson, et al.
Retrovirology|January 23, 2015
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophagesMariluz Araínga, Dongwei Guo, Jayme Wiederin, et al.
Pageof 36

Showing results (71-80 of 354) with videos related to

Sort By:
Pageof 36
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR TherapyJonathan Herskovitz, Mahmudul Hasan, Milankumar Patel, et al.
Antioxidants & Redox Signaling|February 27, 2009
Innate and adaptive immunity for the pathobiology of Parkinson's diseaseDavid K Stone, Ashley D Reynolds, R Lee Mosley, et al.
Neurobiology of Disease|January 2, 2010
HIV-1 neuroimmunity in the era of antiretroviral therapyStephanie D Kraft-Terry, Andrew R Stothert, Shilpa Buch, et al.
Blood|November 16, 2007
STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrierAnathbandhu Chaudhuri, Bo Yang, Howard E Gendelman, et al.
Trends in Microbiology|April 15, 2019
The Promise of Long-Acting Antiretroviral Therapies: From Need to ManufactureHoward E Gendelman, JoEllyn McMillan, Aditya N Bade, et al.
Neuron|October 21, 2009
A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infectionStephanie D Kraft-Terry, Shilpa J Buch, Howard S Fox, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDSStephen Dewhurst, Sanjay B Maggirwar, Giovanni Schifitto, et al.
Communications Biology|July 19, 2025
Unique molecular signatures in rebound viruses from antiretroviral drug and CRISPR-treated HIV-1-infected humanized miceChen Zhang, Haotian Li, Larisa Y Poluektova, et al.
Journal of Parkinson'S Disease|July 24, 2022
Therapeutic Strategies for Immune Transformation in Parkinson's DiseaseMaamoon Saleh, Milica Markovic, Katherine E Olson, et al.
Retrovirology|January 23, 2015
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophagesMariluz Araínga, Dongwei Guo, Jayme Wiederin, et al.
Pageof 36